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Abstract
Background: Telomerase is activated in oncogenesis, which confers an immortal phenotype to cancer cells. The AAA 
+ ATPase Reptin is required for telomerase biogenesis by maintaining telomerase RNA (hTER) stability and is aberrantly 
expressed in certain cancers. Given its role in chromatin remodeling and transcription regulation, we determined the 
effect of Reptin on the transcription of the telomerase reverse transcriptase (hTERT) gene, a key component of the 
telomerase complex and its expression in gastric cancer.
Results: Knocking down Reptin or its partner Pontin using small interfering RNA in gastric and cervical cancer cells led 
to significant decreases in hTERT mRNA, but hTERT promoter activity was inhibited in only Reptin-depleted cells. Reptin 
interacted with the c-MYC oncoprotein and its stimulatory effect on the hTERTpromoter was significantly dependent 
on functional E-boxes in the promoter. Moreover, Reptin bound to the hTERT proximal promoter and the loss of the 
Reptin occupancy led to dissociation of c-MYC from the hTERT promoter in Reptin-depleted cells. Reptin inhibition 
dramatically impaired clonogenic potential of gastric cancer cells by inducing cell growtharrest and over-expression of 
Reptin was observed in primary gastric cancer specimens.
Conclusions: The hTERT gene is a direct target of Reptin, and hTERT transcription requires constitutive expression of 
Reptin and its cooperation with c-MYC. Thus, Reptin regulates telomerase at two different levels. This finding, together 
with the requirementof Reptin for the clonogenic potential of cancer cells and its over-expression in gastriccancer and 
other solid tumors, suggests that Reptin may be a putative therapeutic target.
Background
Telomerase, an RNA-dependent DNA polymerase
responsible for telomere lengthening, is silent in most dif-
ferentiated human cells due to the tight repression of its
catalytic unit, telomerase reverse transcriptase (hTERT) at
the transcriptional level [1-3]. Because activation of
telomerase is a critical step for cellular immortalizatio-
nand transformation [1-4], the mechanisms that control
the precisely regulated switch between repression and
activation of the hTERT gene and telomerase represent a
central question in cancer research. As a multi-unit com-
plex, telomerase activity has been shown to be controlled
at various levels [1-3,5-7], however, it remains incom-
pletely understood how telomerase and hTERT are de-
repressed in oncogenesis.
Reptin and Pontin, two related AAA + ATPases, exert
important biological actions including chromatin remod-
eling, transcription regulation and DNA damage repair
[8,9]. They interact with major oncogenic factors such as
β-catenin and c-MYC [8-12]. A few studies have shown
that Reptin and Pontin are over-expressed in liver and
colon cancers, respectively, and implicated in the patho-
genesis of these cancers [13,14]. More recently, Reptin
and Pontin have been identified as the subunits of the
telomerase complex and they are required for telomerase
assembly or biogenesis through maintaining telomerase
RNA (hTER) stability [15]. Taken together, Reptin and
Pontin are likely involved in carcinogenesis by promoting
* Correspondence: jiajihui@sdu.edu.cn, Dawei.Xu@ki.se
1 Department of Microbiology/Key Laboratory for Experimental Teratology of 
Chinese Ministry of Education, School of Medicine and School of Life Sciences, 
Shandong University, Jinan, PR China
2 Department of Medicine, Division of Hematology, and Center for Molecular 
Medicine (CMM), Karolinska University Hospital Solna and Karolinska Institutet, 
Stockholm, Sweden
† Contributed equally
Full list of author information is available at the end of the articleLi et al. Molecular Cancer 2010, 9:132
http://www.molecular-cancer.com/content/9/1/132
Page 2 of 10
telomerase assembly and/or other mechanisms. Given an
intimate interaction between Reptin/Pontin and the
oncogene c-MYC, and essential role for c-MYC in the
trans-activation of the hTERTgene [1-3,8,9,16-19], we
hypothesize that Reptin and Pontin may regulate telom-
erase by affecting hTERT transcription. In the present
study, we addressed this issue in gastric and cervical can-
cer cells. In addition, to determine the functional conse-
quence and clinical relevance, we studied the effect of
Reptin on the clonogenicpotential of gastric cancer cells
and Reptin expression in primary gastric cancer speci-
mens.
Materials and methods
Cell lines, culture conditions and small interfering RNA 
(siRNA) treatment
Human gastric cancer cell lines AGS, BGC-823 and
HGC-27, and cervical cancer cell lines HeLa and SiHa
used in the present study were cultured at 37°C/95%air/
5%CO2 in RPMI 1640 medium (Life Technologies, Pais-
ley, Scotland, UK) containing 10% fetal calf serum, 100
units/ml penicillin, and 2 mM L-glutamine. For siRNA
treatment, cells were incubated in 6-well plates (1.0 ×
105/well) overnight and were then transfected with
siRNA using Lipofectamine2000 (Invitrogen, Carlsbad,
CA, USA) according to the manufacturer's protocol.
Chemical modified Stealth™ siRNA targeting Reptin,
Pontin and control siRNA (Invitrogen) were 5'- GAG
AUC CAG AUU GAU CGA CCA GCA A -3', 5'-CCA
UGC UGU AUA CUC CAC AGG AAA U-3' and 5'- CCU
ACA UCC CGA UCG AUG AUG UUG A -3', respec-
tively.
RNA extraction, reverse transcription (RT) and real-time 
quantitative PCR (rqPCR)
Total cellular RNA in cell lines and gastric tissues was
extracted using the ULTRASPEC kit (Biotecx Lab., Hous-
ton, TX, USA) or Trizol kit (Invitrogen) according to the
manufacturer's protocols. cDNA was synthesized using
random primers (N6) (Amersham, Buckinghamshire,
UK) and M-MLV reverse transcriptase. The sequences of
the PCR primers were: Reptin: 5'-CGAGGAAGAAGAT-
GTGGAGA-3' (Forward) and 5'-CACTTCTGTACCCT-
TGCGTT -3' (Reverse); Pontin: 5'- GGCATGTGGCGT
CATAGTAGA -3' (Forward) and 5'- CACGGAGT-
TAGCTCTGTGACT -3' (Reverse); hTERT: 5'-CGGAA-
GAGTGTCTGGAGCAA-3' (Forward) and 5'-GG
ATGAAGCGGAGTCTGGA-3' (Reverse); and hTER: 5'-
TCTAACCCTAACTGAGAAGGGCGTAG-3' (Forward)
and 5'-GTTTGCTCTAGAATGAACGGTGGAAG-3'
(Reverse); c-MYC: 5'-TACCCTCTCAACGACAGCAGC
TCGCCCAACTCCT-3' (Forward) and 5'-TCTTGACA
TTCTCCTCGGTGTCCGAGGACCT-3' (Reverse). β2-
microglobulin (β2-M) expression was used as a control
for RNA loading and RT efficiency and amplified. rqPCR
was carried out in an ABI7700 sequence detector
(Applied Biosystems, Foster City, CA) using a SYBR
Green kit (Applied Biosystems). Levels of hTERT, hTER,
Reptin and c-MYC mRNA were calculated based on the
threshold cycle (CT) values and normalization of human
β2-M expression.
Assessment of telomerase activity
Telomerase activity was assayed with a commercial
Telomerase PCR ELISA kit (Roche Diagnostics Scandina-
via AB, Stockholm, Sweden) according to the manufac-
turer's instruction. Total cellular proteins were extracted
using CHAPS lysis buffer. For each assay, 0.5 μg of protein
was used, and 26 PCR cycles were performed after the
telomerase-primer elongation reaction. The PCR prod-
ucts were detected with an ELISA color reaction. The
measured telomerase activity was expressed as absor-
bance [optimal density (OD) in arbitrary units].
Immunoprecipitation (IP) and immunoblotting
Total cellular proteins were extracted with RIPA lysis buf-
fer. For IP, cellular proteins (200 μg) were precipitated
with 5 μg of polyclonal antibodies against c-MYC (Santa
Cruz Biotechnologies, Santa Cruz). Five μg of rabbit IgG
served as an isotype control in IP experiments. The pre-
cipitated material, or 20 μg of protein in case of western
blot for Reptin and c-MYC analyses, was subjected to
sodium dodecyl sulfate-polyacrylamide gel electrophore-
sis and transferred to a nitrocellulose membrane. The
membranes were probed with the specific monoclonal
antibody against Reptin (BD, Franklin Lakes, USA) or
polyclonal antibody c-MYC (Santa Cruz Biotechnologies)
followed by anti-mouse or rabbit horseradish peroxidase-
conjugated IgG and developed with the enhanced chemi-
luminescent method (ECL, Amersham). β-actin immu-
noblot was performed as a loading control.
Colony formation assay
Cells were transfected with control, Reptin or Pontin
siRNA for 72 hours, and were then seeded into six well-
plates (300 cells/well) and incubated for 10 days, as
described [20]. Plates were stained with Giemsa and the
number of colonies with > 50 cells was counted.
Assay for the hTERT promoter activity in cells with Reptin or 
Pontin depletion
The hTERT promoter reporter plasmid p181wt harboring
the core promoter sequence of the hTERT 5'-flanking
region and its mutant variant (p181MYC-) lacking the
functional c-MYC motifs (E-boxes) were described previ-
ously [17,21]. Cells cultured in 24-well plates were first
transfected with Reptin or Pontin siRNA using Lipo-
fectamine 2000 (Invitrogen). The next day, transfection of
p181wt and p181MYC- plasmids was performed. A RenillaLi et al. Molecular Cancer 2010, 9:132
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reniformis luciferase-containing plasmid, which is under
control of the thymidine kinase promoter, was co-trans-
fected to monitor the transfection efficiency. Luciferase
activity in the cell lysates was determined by using a dual
luciferase reporter assay system (Promega, WI) 48 hours
post-transfection of the promoter reporter, and the
hTERT  promoter-driven firefly luciferase activity was
normalized to the thymidine kinase renilla activity and
expressed as percentage of that in control cells.
Chromatin immunoprecipitation (ChIP)
ChIP assays were performed as described previously
[22,23]. DNA was cross-linked by exposing the cells to
medium containing 1% (vol/vol) formaldehyde for 10
minutes at 37°C and then sonicated to make soluble chro-
matin with DNA fragments from 200 to 1000 base pairs.
Antibodies against Reptin (BD), c-MYC (Santa Cruz Bio-
technologies) and acetylated histone H3 (Millipore,
Temecula, CA) were used to precipitate DNA fragments
bound by their corresponding elements. In negative con-
trol assays, rabbit IgG were added. The protein-DNA
complex was collected with protein A/G-Sepharose beads
(Millipore), eluted, and reverse cross-linked. After treat-
ment with protease K (Sigma), DNA was extracted with
phenol-chloroform and precipitated with ethanol. The
recovered DNA was re-suspended in Tris-EDTA buffer
and amplified by PCR with following primer pairs:
hTERT  proximal promoter: 5'-CCAGGCCGGGCTC-
CCAGTGGAT-3' (Forward), and 5'-GGCTTCCCACGT-
GCGCAGCAGGA-3' (Reverse). To further control for
nonspecific antibody binding, the 3' region of GAPDH
gene was PCR-amplified in parallel using the following
primers: 5'-AAAGGGCCCTGACAACTCTT-3' (For-
ward) and 5'-GGTGGTCCAGGGGTCTTACT-3'
(Reverse).
Cell cycle analysis
Cells transfected with control and Reptin siRNA were
harvested at 48 hrs, fixed with 70% ethanol at + 4°C over-
night and stained with RNAse A (0.5 μg)-containing Pro-
pidium Iodide (PI, 50 μg/ml). Cell cycle distribution was
determined using flow cytometry with ModFit.
Patient samples and immunohistochemistry
Paraffin-embedded primary tumor specimens and their
matched normal tissues were obtained from 20 gastric
cancer patients who were admitted to Shandong Univer-
sity Qilu Hospital during 2007 [20,24]. The tissue speci-
mens were de-paraffinized and rehydrated and the
antigens retrieved in a microwave oven (0.01 M citrate
buffer, pH 6.0). A mouse monoclonal antibody against
Reptin (1:250) (BD) was then added onto the sections and
incubated over-night at + 4°C. Goat anti-mouse IgG con-
jugated HRP and DAB staining (Vector Laboratories,
Burlingame, CA, USA) were employed to visualize Reptin
antibody binding. The slides were finally counterstained
with hematoxylin. Mouse IgG instead of Reptin antibody
was run in parallel as negative controls. A microscope
(Olympus BX60, T okyo, Japan) equipped with a digital
camera (Sony DKC-5000, Tokyo, Japan) was employed
for staining analysis. The result was expressed as percent-
age of staining-positive cells. The study was approved by
the local Ethics Committee.
Statistical analyses
The comparison of hTERT mRNA, promoter activity and
telomerase activity, c-MYC expression and foci numbers
between control and siRNA-treated cells was made using
a Student's t-test or Mann-Whitney U-test. The differ-
ence in Reptin expression between tumors and adjacent
normal gastric tissues as detected by immunohistochem-
istry was analyzed using Mann-Whitney U-test. A regres-
sion analysis was carried out to determine the correlation
between hTERT and Reptin mRNA expression in gastric
samples. All the tests were two-tailed and computed
using SigmaStat3.1® software (Systat Software, Inc., Rich-
mond, CA). P values less than 0.05 were considered sta-
tistically significant.
Results
Reptin is required for constitutive hTERT mRNA expression 
in gastric and cervical cancer cells
Reptin were expressed at substantial levels in a panel of
gastric and cervical cancer cell lines by immunoblotting
assays (Fig. 1a). We silenced Reptin in those cells using its
specific siRNAs. Efficient inhibition of Reptin was veri-
fied (Fig. 1a). rqPCR results showed a significant decline
in hTERT mRNA expression in all three gastric cell lines
treated with Reptin sequence-specific siRNA (Fig. 1B). To
determine whether this is cell type-specific, the effect of
Reptin depletion on hTERT mRNA expression was fur-
ther evaluated in cervical cancer cell lines including HeLa
and SiHa and we obtained identical decline in hTERT
mRNA as seen in gastric cancer cells (Fig. 1B, control vs
Reptin siRNA, P < 0.01). Thus, we conclude that Reptin is
required for constitutive hTERT mRNA expression in
g a s t r i c  a n d  c e r v i c a l  c a n c e r  c e l l s .  C o n s i s t e n t  w i t h  t h e
observations by Venteicher et al [15], we found that
telomerase activity was significantly reduced in these
cells (Fig. 1C, P < 0.01 in all Reptin siRNA-treated cells vs
their corresponding control siRNA-treated cells). Of
note, the decline in telomerase activity was less impres-
s i v e  c o m p a r e d  t o  t h a t  o f  h T E R T  m R N A  i n  R e p t i n -
depelted cells, likely due to a relative longer half-life of
telomerase activity [6]. In addition, the level of hTER, the
telomerase RNA template, was also decreased in cells
treated with Reptin siRNA (data not shown).Li et al. Molecular Cancer 2010, 9:132
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Because it has been shown that Reptin and its partner
Pontin mutually depend on each other for their stability
and either Reptin or Pontin sequence-specific siRNA co-
depletes both of them [15], we tested if this was the case
in the present setting. Pontin siRNA treatment indeed led
to diminished levels of Reptin protein expression (Fig.
1A), despite a constant level of Reptin mRNA (data not
shown). Significantly reduced hTERT mRNA and telom-
erase activity was similarly observed in Pontin-depleted
cells (Fig. 1B and 1C, control vs Pontin siRNA: hTERT
mRNA, P < 0.01; telomerase activity, P < 0.05).
Combined treatment of cells with both Reptin and Pontin 
siRNAs leads to an additive decrease in hTERT mRNA
Despite the fact that either Reptin or Pontin sequence-
specific siRNA leads to co-depletion of both proteins, we
treated HGC-27 and HeLa cells with both Reptin and
Pontin specific siRNAs to examine their combined action
on hTERT mRNA expression. For this purpose, we uti-
lized half the concentration of each siRNA for transfec-
tion, which led to weaker but significant inhibition of
hTERT mRNA expression by each of them (Fig 1D, con-
trol vs Pontin or Reptin siRNA, P < 0.01). The combina-
t ion o f  bo t h s iRNAs  r es ult ed in an a ddit ive  decl ine  in
hTERT  m R N A  e x p r e s s i o n  c o m p a r e d  t o  t h a t  i n  c e l l s
treated with either siRNA alone (Fig. 1D, Pontin or Rep-
tin siRNA vs both of them, P < 0.05).
Reptin depletion results in a decrease in hTERT promoter 
activity significantly dependent on c-MYC
To probe whether Reptin and Pontin inhibited hTERT
expression at the transcription level, we examined the
effect of Reptin and Pontin depletion on the hTERT pro-
moter activity. For this purpose, an hTERT reporter con-
struct (p181wt) [17] that harbors the hTERT proximal
promoter sequence were transfected into Reptin- and
Pontin-specific siRNA-treated AGS and HGC-27 cells.
Compared to that in control cells, Reptin depletion led to
a significant reduction in the p181wt -driven luciferase
activity (Fig. 2a and 2B). In contrast, p181wt activity was
slightly increased in the cells treated with Pontin siRNA.
Because Reptin has been shown to cooperate with c-
MYC in regulating gene transcription [11,25,26], we fur-
ther determined whether this effect of Reptin depended
on c-MYC. We assessed the luciferase activity driven by
the p181wt variant p181MYC- where two c-MYC binding
motifs (E-boxes) on the promoter were inactivated by
mutagenesis [17]. The inhibitory effect of Reptin deple-
tion on the p181MYC- activity became substantially weaker
than on p181wt (Fig. 2A and 2B), suggesting that Reptin
regulates the hTERT promoter activity in a MYC-depen-
dent fashion. Again, Pontin inhibition increased the
p181MYC-activity even more compared to that of p181wt,
especially in HGC-27 cells (Fig. 2A and 2B).
Figure 1 Reptin depletion leads to reduced hTERT mRNA expres-
sion and telomerase activity in gastric and cervical cancer cells. C, 
P and R: Control, Pontin and Reptin siRNA, respectively. Bars: Standard 
deviations. The results were obtained from three to four independent 
experiments. (A) Reptin protein expression in gastric and cervical can-
cer cells and efficiency of Reptin knocking down by siRNA. Cells were 
treated with control, Reptin or Pontin siRNA for 72 hours and then an-
alyzed for Reptin expression by immunoblotting assay. (B) Reduced 
hTERT mRNA expression in Reptin or Pontin siRNA-treated cells. The 
same sets of cells from as above were used to determine hTERT mRNA 
using rqPCR. Relative levels of hTERT mRNA are shown. (C) Reduced te-
lomerase activity in Reptin or Pontin siRNA-treated cells. Cellular pro-
teins were extracted from the cells above and telomerase activity was 
assessed using a Telomerase ELISA kit. The enzymatic activity was ex-
pressed as absorbance [optimal density (OD) in arbitrary units]. (D) Ad-
ditive inhibitory effect on hTERT mRNA expression in cells treated with 
combination of Reptin and Pontin siRNAs. HGC-27 and HeLa cells were 
treated with Reptin or Pontin siRNA alone or both of them at the half 
concentration used in (B) and hTERT mRNA abundance was analyzed 
with rqPCR. Relative levels of hTERT mRNA are shown.
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Figure 2 Reptin cooperates with c-MYC to regulate the hTERT promoter activity. (A and B) c-MYC-dependent inhibition of the hTERT promoter 
activity by Reptin depletion. AGS and HGC-27 cells were first treated with control (C), Reptin (R) or Pontin (P) siRNA and then transfected with either 
p181wt or its c-MYC mutant variant p181MYC-. Luciferase activity was assessed using a dual luciferase detection kit 48 hours after transfection and rel-
ative luciferase activity was obtained from its normalization by co-transfected thymidine kinase renilla activity and expressed as percentage of that in 
control cells. Bars: Standard deviation. * and **: P < 0.05 and 0.01, respectively. Bars: Standard deviations. NS: Not significant. Three independent ex-
periments were performed. (C) Concomitant presence or absence of Reptin and c-MYC on the hTERT promoter. AGS and HGC-27 cells were treated 
with control or Reptin siRNA and chromatin immunoprecipitation was then performed to examine the association between the hTERT promoter se-
quence and Reptin, c-MYC, or acetylated histone H3. (D) c-MYC expression in Reptin-depleted gastric cancer cells as determined by using rqPCR (Left 
panel) and western blot (Right panel). NS: Not significant and **: P < 0.01. (E) Physical interaction between Reptin and c-MYC as demonstrated using 
immunoprecipitation. Cellular proteins derived from AGS and BGC-823 cells were precipitated by a c-MYC antibody followed by detection using the 
antibody against Reptin. Rabbit IgG was used as a negative control. Two independent experiments were performed with similar results.
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Reptin occupies the hTERT promoter and its depletion 
abolishes the association of both Reptin and c-MYC with 
the hTERT promoter
The ChIP assay revealed that the hTERT promoter was
bound by Reptin in AGS and HGC-27 cells, and such an
association disappeared when Reptin was knocked down
(Fig. 2C). We further found the concomitant absence of c-
MYC on the promoter upon Reptin depletion ((Fig. 2C).
Moreover, the acetylation of histone H3 in the hTERT
promoter region was reduced in Reptin-depleted cells
(Fig. 2C), suggesting a condensed chromatin structure
consistent with lower transcription activity of the hTERT-
gene [27-29].
Undetectable MYC occupancy on the hTERT promoter
may result from either down-regulation of c-MYC, or an
impaired binding ability. To distinguish between these
two scenarios, we determined c-MYC mRNA and protein
levels in Reptin-depleted cells. Reptin siRNA-treatment
led to a significant down-regulation of c-MYC expression
in HGC-27 cells but not in AGS and BGC-823 cells (Fig.
2D). These results indicate defects in MYC binding to
target promoters in the absence of Reptin.
Reptin interacts with c-MYC
An interaction between Reptin and c-MYC has been
observed in cells from different species [11,25,26], which
is required for the transcriptional regulation of c-MYC
target genes. To investigate whether this is the case in
gastric cancer cells, we immunoprecipitated c-MYC-
bound proteins using a c-MYC specific antibody and then
performed immunoblotting analyses with an antibody
against Reptin. The IP result demonstrated that Reptin
was physically associated with c-MYC (Fig. 2E). Reptin
and Pontin also interacted with each other in these cells
(data not shown).
Reptin-depleted gastric cancer cells show impairment of 
the clonogeneic potential and cell growth arrest
Telomerase or hTERT affects sustained cell proliferation
through different mechanisms [30,31]. Given the findings
described above, we sought to determine whether Reptin
is required for the clonogenic potential of immortal can-
cer cells. To this end, we assessed the foci formation abil-
ity of the cells treated with Reptin siRNA. As shown in
Fig. 3, Reptin depletion resulted in dramatic reduction in
foci numbers of gastric cancer cells (Control siRNA vs
Reptin siRNA in all three cell lines, P < 0.01. AGS (Mean
± SD): 42 ± 4 vs 0 ± 1; BGC-823: 152 ± 12 vs 4 ± 3 and
HGC-27: 162 ± 41 vs 16 ± 11). Of note, AGS cells com-
pletely lost their clonogenic potential when Reptin was
knocked down (Fig. 3A). Flow cytometry analyses dem-
onstrated that these Reptin siRNA-treated cells under-
went growth arrest at G1 phase (Fig. 3B). Lack of sub-G1
(Fig. 3B) and neglectable annexin V staining (data not
shown) suggest that Reptin inhibition does not induce
apoptosis of AGS and HGC-27 cells.
Reptin is over-expressed in primary gastric cancer
We further assessed whether Reptin expression was
altered in primary gastric cancer. Tumor specimens and
their matched normal tissues derived from 20 patients
with gastric cancer were analyzed by immunohistochem-
istry. In normal gastric mucosa, the majority of cells were
negative for Reptin staining while a small fraction of cells
had Reptin signals with variable intensity that were local-
ized to the nucleus (Fig. 4A and 4B). However, in tumors,
most cells were Reptin-positive with a much stronger
staining (78 ± 8%, Mean ± SD) (Fig. 4A and 4C), which
was significantly higher than those in matched normal
tissues (17 ± 7%, Mean ± SD, tumors vs normal, P < 0.01).
Tumor cells were in general stained homogenously,
although there was heterogeneity to a certain extent. Sim-
ilar to that seen in matched normal tissues, Reptin signals
were predominantly distributed in the nucleus of tumor
cells (Fig. 4C).
Reptin mRNA expression is correlated with hTERT transcript 
level in gastric tissues
We finally determined whether Reptin and hTERT
expression was associated with each other in primary
gastric tissues. Twenty normal and cancerous gastric
samples were analyzed for Reptin and hTERT mRNA
abundance using rqPCR, and as shown in Fig. 4D, we
found a positive correlation between them (R2 = 0.202, P
= 0.044), which indicates that Reptin over-expression
likely has an in vivo stimulatory effect on the hTERT tran-
scription.
Discussion
Regulation of gene transcription is one important func-
tion of Reptin and Pontin, and likely achieved through
two different mechanisms [8,9]. First, both Reptin and
Pontin are integral subunits of different chromatin-modi-
fying complexes such as ATP-dependent helicase Ino80-
and Tip60-containing histone acetyltransferase (HAT)
complexes. Second, they interact physically with various
sequence-specific transcription factors, among which is
the oncogene c-MYC [26,32]. Because MYC also recruits
the Tip60 HAT complex to its target promoters [32,33], a
link between Reptin and c-MYC apparently occurs at two
different levels. With this background in mind, we deter-
mined the effect of Reptin and Pontin on hTERT expres-
sion. Here we show the hTERT  gene is a direct
transcription target of Reptin: (i) Knocking down Reptin
led to a significant decline in hTERTmRNA expression
and hTERT promoter activity; and (ii) Reptin occupied
the hTERT  proximal promoter. It was further observed
that the functional c-MYC binding motifs on the hTERTLi et al. Molecular Cancer 2010, 9:132
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Figure 3 Reptin depletion severely impairs the clonogenic potential and growth of gastric cancer cells. (A) Cells were transfected with Reptin 
siRNA for 72 hours and then seeded into six-well plates (300 cells/well). After ten days, Giemsa staining was performed and the foci number was doc-
umented. Six independent experiments were performed. (B) AGS and HGC-27 cells treated with Control and Reptin siRNA were analyzed for cell cycle 
distribution using flow cytometry with ModFit. Two independent experiments were performed with similar results.
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G2/M:  7.79 % 
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0 30 60 90 120 150
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S3 2 2 2 %
G1:    67.50 %
S: 22 41 %
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promoter activity was required for Reptin depletion-
mediated reduction of the promoter activity and that c-
MYC failed to bind to the hTERT promoter without Rep-
tin. Therefore, Reptin affects the hTERT transcription in
a MYC-dependent manner. Our findings, together with
the observation showing Reptin being a required factor
for telomerase assembly, demonstrate that Reptin regu-
lates telomerase activity through two different mecha-
n i s m s .  A s  t e l o m e r a s e  h a s  b e e n  s u g g e s t e d  a s  a  c a n c e r
therapeutic target, manipulating Reptin may be a novel
approach for telomerase inhibition in cancer cells.
Reptin and Pontin are known to antagonize each other
in regulating transcription of certain target genes [12,34-
36]. It is not surprising to identify a differential effect on
hTERT transcription between Pontin and Reptin. Like
Reptin, Pontin interacts with c-MYC and its depletion
leads to diminished hTERT  mRNA expression. Reptin
protein level was concomitantly reduced when Pontin
was knocked down in all the examined cells. However,
depleting Pontin slightly increased rather than inhibited
hTERT promoter activity, in sharp contrast to that seen in
cells treated with Reptin siRNA. It is currently difficult to
understand that Reptin and Pontin depletion inhibits
hTERT mRNA expression on the one hand while each of
them has different effects on the hTERT promoter activ-
ity on the other. Nevertheless, the results collectively
indicate that Pontin and Reptin regulate hTERT mRNA
expression through different mechanisms.
Reptin depletion led to a significant reduction in foci
numbers of gastric cancer cells, indicating that constitu-
tive expression of Reptin is essential for their clonogenic
potential. Such defective clonogenesis may be attribut-
able to down-regulation of hTERT expression and telom-
erase activity, impaired c-MYC function and/or down-
regulation, and growth arrest taking place in Reptin-
depleted cancer cells. Indeed, hTERT or telomerase inhi-
bition compromises sustained proliferation and tumori-
genic ability of cancer cells [30,31] while the c-MYC-
mediated cellular transformation is severely attenuated if
without Pontin and Reptin [32]. Moreover, given diverse
biological activities of Reptin [8], other unidentified
mechanisms are likely involved in Reptin-mediated can-
cer cell growth and clonogenic ability.
Reptin and Pontin were previously reported to be
expressed ubiquitously in normal human tissues [8], how-
ever, their enhanced expression has been observed in dif-
ferent types of cancer. We show here a general increase in
Reptin expression in primary gastric cancer, potentially
indicating its clinical relevance. Little is at present known
about the regulatory mechanism of Reptin expression.
The oncogene c-MYC, frequently dysregulated in gastric
cancer [24], has been shown to significantly enhance Rep-
Figure 4 Reptin is over-expressed in primary gastric cancer. Im-
munohistochemistry was performed to determine Reptin expres-
sion. (A) Overall Reptin-positive cells in gastric cancer specimens and 
their matched normal tissues from 20 patients. (B) and (C) Representa-
tive of Reptin staining on normal and cancerous gastric tissues, respec-
tively (Magnification × 400). Left panels: The enlarged areas of right 
panels in the rectangles. (D) Positive correlation between Reptin and 
hTERT mRNA levels in primary gastric tissues. The abundance of Reptin 
and hTERT mRNA in 20 normal and cancerous gastric tissues was as-
sessed using rqPCR as described in Materials and methods.
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tin expression [8]. We also observed the requirement of c-
MYC for Reptin expression (WL and DX, unpublished
data). Thus, the over-expression of Reptin observed in
gastric cancer likely results from the elevated c-MYC
level. In that setting, Reptin and c-MYC may form a posi-
tive feedback loop to regulate their expression and func-
tional activities.
Conclusion
In the present study, we demonstrated that Reptin was
required for constitutive hTERT  mRNA expression in
gastric and cervical cancer cells. The depletion of Reptin
led to significant decreases in hTERT  mRNA and pro-
moter activity by impairing c-MYC-dependent hTERT
transcription. It was further shown that the Reptin-
depleted cancer cells exhibited highly defective clonogen-
esis and cell cycle arrest. Finally, Reptin was observed to
be over-expressed in primary gastric cancer. Collectively,
Reptin may play an important role in the pathogenesis of
gastric and other cancers, and targeting Reptin may thus
be implicated in cancer therapy acting through inhibition
of telomerase activity or other undefined mechanisms.
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